Wenqun Xing
Zhengzhou University(CN)Henan Cancer Hospital(CN)
Publications by Year
Research Areas
Esophageal Cancer Research and Treatment, Gastric Cancer Management and Outcomes, Lung Cancer Diagnosis and Treatment, Esophageal and GI Pathology, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Neoadjuvant chemotherapy combined with immunotherapy versus neoadjuvant chemoradiotherapy in patients with locally advanced esophageal squamous cell carcinoma(2024)51 cited
- → Perioperative toripalimab plus neoadjuvant chemotherapy might improve outcomes in resectable esophageal cancer: an interim analysis of a phase III randomized clinical trial(2024)30 cited
- → Perioperative Outcomes and Learning Curve of Robot-Assisted McKeown Esophagectomy(2022)10 cited
- → Abstract CT126: Aumolertinib as adjuvant therapy in patients with stage II-IIIB EGFR-mutated NSCLC after complete tumor resection: A randomized, double-blind, placebo-controlled, phase 3 trial (ARTS)(2025)2 cited
- → The safety of neoadjuvant chemotherapy combined with non-tube nofasting fast-track surgery for esophageal carcinoma(2022)2 cited
- → Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA(2024)1 cited
- → Relationship between postoperative complications of esophageal cancer surgery and season: a retrospective study(2022)1 cited
- → A multimodal synergistic model for personalized neoadjuvant immunochemotherapy in esophageal cancer(2025)
- → Initial experience with modified en bloc robot‐assisted minimally invasive oesophagectomy for thoracic oesophageal squamous cell carcinoma(2023)
- → Harnessing TAGAP to improve immunotherapy for lung squamous carcinoma treatment by targeting c-Rel in CD4+ T cells(2025)